My research program exists at the intersection between engineering, molecular biology, and biophysics and is focused on developing imaging tools to report gene expression in living subjects.

MRI-detectable expression reporters for translational molecular imaging

I recently discovered that the manganese transport protein, Zip14, can be applied as a genetically encoded, MRI-visible expression reporter agent (analogous to GFP for MRI). I call this system Manganese Accumulation for Genetically Inducible Contrast (MAGIC) MRI. MAGIC is produced using clinically standard MRI hardware and pulse sequences. I used MAGIC to detect long-range neural connectivity and glia populations in the living rodent brain. In situ, spatially resolved mass spectrometry revealed that MAGIC is produced by accumulation of endogenous manganese, and no other agents are necessary. I have also demonstrated MAGIC in the nonhuman primate brain. This work has been published in Magnetic Resonance in Medicine, a follow up paper is under revision, and a patent application has been filed for this technology.

Cellular resolution MRI and high-throughput imaging pipelines

I used the exquisite cytoarchitectural contrast afforded by Manganese-enhanced MRI (MEMRI) to perform in vivo cellular resolution imaging of the mouse cerebellum. I selectively ablated cell type populations in the Purkinje cell layer to discover that a single cell type, Purkinje neurons, were responsible for the uptake of manganese. These results resolved a ~20 year inconsistency in the field and triggered the search for molecular mechanisms for manganese uptake which motivated MAGIC. Earlier, my thesis research applied MEMRI as a high-throughput screening tool for mouse models of human disease. I built a statistical classifier that predicted spontaneous tumor progression or regression in a model of human medulloblastoma, and it served as the basis for a preclinical trial of a novel anti-tumor-associated macrophage therapy. I also developed MEMRI contrast into a quantifiable biomarker for progressive degeneration of Purkinje neurons in a model of Niemann-Pick Type C disease. This work was published in NeuroImage and Magnetic Resonance in Medicine.

Research program

My laboratory will develop MAGIC into a platform for reporting gene expression in living subjects. Gene and RNA therapies are dosed without knowing how much reached the target. In animals that is measured only after the subject is sacrificed. In people it is inferred from whether the patient improves, too late to separate an underdose from a delivery failure. MAGIC answers the question in the same subject, repeatedly, on clinical hardware. I have already demonstrated its efficacy in the rodent and macaque brain. In my laboratory, I will push its detection limit with AI/ML and calibrate signal against expressing-cell number, so an image reads as an expression level. I will use MAGIC to guide dosing in a disease model with a narrow therapeutic window. I will also engineer MAGIC agents gated on a chosen transcript, so the image reports function as well as location.


I am currently a postdoctoral Research Fellow in the Section on Plasticity and Imaging of the Nervous System at the NINDS/NIH, working with Dr. Alan Koretsky. I am the recipient of an NIBIB/NIH K99/R00 Pathway to Independence Award.

Highlights

All news →